Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-02-27

Clinical Trial Update: Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation [NA]

View source ↗

Summary

This clinical trial update reports that the study of epoetin alfa to treat anemia after kidney transplantation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Mehrotra, Anita, M.D. | Conditions: Anemia | NA | Status: TERMINATED